Li Tu

753 total citations
27 papers, 580 citations indexed

About

Li Tu is a scholar working on Neurology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Li Tu has authored 27 papers receiving a total of 580 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Neurology, 7 papers in Oncology and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Li Tu's work include Intracranial Aneurysms: Treatment and Complications (7 papers), Traumatic Brain Injury and Neurovascular Disturbances (7 papers) and Cancer Cells and Metastasis (3 papers). Li Tu is often cited by papers focused on Intracranial Aneurysms: Treatment and Complications (7 papers), Traumatic Brain Injury and Neurovascular Disturbances (7 papers) and Cancer Cells and Metastasis (3 papers). Li Tu collaborates with scholars based in China, Germany and United States. Li Tu's co-authors include Shuaidong Huo, Zheng Luo, Yun‐Long Wu, Zhihuan Liao, Andreas Herrmann, Yanyang Liu, Zhen Sun, Feng Luo, Yuyi Wang and Feng Luo and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Journal of Colloid and Interface Science.

In The Last Decade

Li Tu

22 papers receiving 571 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Li Tu China 14 218 171 112 97 96 27 580
Meng-jun Qiu China 13 174 0.8× 188 1.1× 65 0.6× 70 0.7× 107 1.1× 28 535
Qi Yue China 14 270 1.2× 282 1.6× 51 0.5× 126 1.3× 88 0.9× 32 776
Dun Wang China 14 174 0.8× 197 1.2× 42 0.4× 139 1.4× 90 0.9× 35 544
Xiaoning Lin China 11 357 1.6× 183 1.1× 157 1.4× 187 1.9× 109 1.1× 27 713
Yuanlin Xu China 12 324 1.5× 135 0.8× 162 1.4× 42 0.4× 82 0.9× 33 715
Safwan Alomari United States 10 174 0.8× 191 1.1× 56 0.5× 138 1.4× 67 0.7× 22 557
April D. Harrison United States 11 272 1.2× 180 1.1× 73 0.7× 97 1.0× 135 1.4× 13 599
Tsang-Pai Liu Taiwan 15 348 1.6× 147 0.9× 95 0.8× 138 1.4× 89 0.9× 23 747
Amy Buckley Ireland 8 265 1.2× 74 0.4× 151 1.3× 30 0.3× 117 1.2× 16 533
Mengting Zhu China 12 187 0.9× 137 0.8× 44 0.4× 50 0.5× 64 0.7× 34 517

Countries citing papers authored by Li Tu

Since Specialization
Citations

This map shows the geographic impact of Li Tu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Li Tu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Li Tu more than expected).

Fields of papers citing papers by Li Tu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Li Tu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Li Tu. The network helps show where Li Tu may publish in the future.

Co-authorship network of co-authors of Li Tu

This figure shows the co-authorship network connecting the top 25 collaborators of Li Tu. A scholar is included among the top collaborators of Li Tu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Li Tu. Li Tu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Tu, Li, et al.. (2025). Good responses to first-line immunotherapy-included treatment in lung squamous carcinoma with rare driver gene mutations: a report of three cases. Translational Lung Cancer Research. 14(6). 2337–2346. 1 indexed citations
3.
Tu, Li, Huiling Chen, Zhenqing Hou, et al.. (2024). Amino acid-based metallo-supramolecular nanoassemblies capable of regulating cellular redox homeostasis for tumoricidal chemo-/photo-/catalytic combination therapy. Journal of Colloid and Interface Science. 663. 810–824. 8 indexed citations
4.
5.
6.
7.
Lin, Fa, Runting Li, Yú Chen, et al.. (2023). Insular cortex Hounsfield units predict postoperative neurocardiogenic injury in patients with aneurysmal subarachnoid hemorrhage. Annals of Clinical and Translational Neurology. 10(12). 2373–2385.
8.
Tu, Li, Jun Zhang, Runting Li, et al.. (2023). Elevated markers of early fibrinolysis disorder as predictors of poor 90-day prognosis in patients with aneurysmal subarachnoid hemorrhage: A large prospective cohort study. Journal of Stroke and Cerebrovascular Diseases. 32(12). 107433–107433. 2 indexed citations
9.
10.
Tu, Li, Zhihuan Liao, Zheng Luo, et al.. (2021). Ultrasound‐controlled drug release and drug activation for cancer therapy. SHILAP Revista de lepidopterología. 1(3). 20210023–20210023. 147 indexed citations
11.
Tu, Li, Zheng Luo, Yun‐Long Wu, Shuaidong Huo, & Xing‐Jie Liang. (2021). Gold-based nanomaterials for the treatment of brain cancer. Cancer Biology and Medicine. 18(2). 372–387. 32 indexed citations
12.
Tu, Li, Zhongxiong Fan, Fukai Zhu, et al.. (2020). Self-recognizing and stimulus-responsive carrier-free metal-coordinated nanotheranostics for magnetic resonance/photoacoustic/fluorescence imaging-guided synergistic photo-chemotherapy. Journal of Materials Chemistry B. 8(26). 5667–5681. 36 indexed citations
13.
Wang, Li, Jun He, Haoyue Hu, et al.. (2020). Lung CSC‐derived exosomal miR‐210‐3p contributes to a pro‐metastatic phenotype in lung cancer by targeting FGFRL1. Journal of Cellular and Molecular Medicine. 24(11). 6324–6339. 76 indexed citations
14.
Tian, Li, Li Tu, Ran Gu, et al.. (2020). Neuroprotection of GLP-1/GIP receptor agonist via inhibition of mitochondrial stress by AKT/JNK pathway in a Parkinson's disease model. Life Sciences. 256. 117824–117824. 21 indexed citations
15.
Tu, Li, Qian Zhang, Ran Gu, et al.. (2020). <p>Neuroprotective effect and mechanism of baicalin on Parkinson’s disease model induced by 6-OHDA</p>. Neuropsychiatric Disease and Treatment. Volume 15. 3615–3625. 18 indexed citations
16.
17.
Wang, Yuyi, Li Tu, Yanyang Liu, et al.. (2018). CXCR2 is a novel cancer stem-like cell marker for triple-negative breast cancer. OncoTargets and Therapy. Volume 11. 5559–5567. 20 indexed citations
18.
19.
Tu, Li, Xiujuan Liu, Tian Li, et al.. (2018). Admission Serum Calcium Level as a Prognostic Marker for Intracerebral Hemorrhage. Neurocritical Care. 30(1). 81–87. 22 indexed citations
20.
Zhang, Nan, Yanyang Liu, Yuyi Wang, et al.. (2017). Decitabine reverses TGF-&beta;1-induced epithelial&ndash;mesenchymal transition in non-small-cell lung cancer by regulating miR-200/ZEB axis. Drug Design Development and Therapy. Volume11. 969–983. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Meng-jun Qiu Breakdown of academic impact, for papers by Qi Yue Breakdown of academic impact, for papers by Dun Wang Breakdown of academic impact, for papers by Xiaoning Lin Breakdown of academic impact, for papers by Yuanlin Xu Breakdown of academic impact, for papers by Safwan Alomari Breakdown of academic impact, for papers by April D. Harrison Breakdown of academic impact, for papers by Tsang-Pai Liu Breakdown of academic impact, for papers by Amy Buckley Breakdown of academic impact, for papers by Mengting Zhu
Rankless by CCL
2026